AIRWEIGHS: A Randomized Controlled Trial of Air Cleaners in Normal Weight and Overweight/Obese Children With Asthma

Anna Y Qiu1, Emily P Brigham2, Han Woo1

  • 1Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.

Insights

Air cleaners reduced indoor air pollution for children with asthma, but did not improve asthma symptoms or outcomes, regardless of weight status. This study highlights the need for further research into effective asthma management strategies.

Area of Science:

  • Environmental Health
  • Pediatric Asthma
  • Air Pollution Research

Background:

  • Overweight and obesity are linked to increased asthma severity in children.
  • These children may be more vulnerable to the effects of air pollution.

Purpose of the Study:

  • To investigate if air cleaner interventions reduce indoor air pollution more effectively in overweight/obese children with asthma compared to normal-weight children.
  • To assess the differential impact of reduced indoor air pollution on asthma outcomes between these two groups.

Main Methods:

  • The AIRWEIGHS trial was a randomized, placebo-controlled study involving children with asthma.
  • Participants received either a functional air cleaner or a placebo device for 12 weeks.
  • Asthma symptoms, lung function, and home air pollution levels were measured.

Main Results:

  • Air cleaners significantly reduced ultrafine particles (UFP), PM2.5, PM10, and NO2 levels.
  • Despite effective pollution reduction, no improvements were observed in primary or secondary asthma outcomes.
  • No significant differences in outcomes were found between normal-weight and overweight/obese children.

Conclusions:

  • Portable air cleaners are effective at reducing indoor air pollution.
  • However, this intervention did not yield observable benefits for asthma outcomes in children, irrespective of weight status.
Abstract

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
607
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.6K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.9K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
489